Latest News in the pharma Industry

Research & Development

Novartis' Entresto could prevent or postpone over 28,000 US deaths per year among HFrEF patients

Novartis' Entresto could prevent or postpone over 28,000 US deaths per year among HFrEF patients

23 Jun 2016

A new analysis published in JAMA Cardiology is the first to quantify the possible impact of Entresto's potential benefit in reducing death.

Read more 
Leukemia has largest pipeline and most first-in-class innovation in hematological cancers space

Leukemia has largest pipeline and most first-in-class innovation in hematological cancers space

22 Jun 2016

Of the three major indications within hematological cancer, namely leukemia, lymphoma and myeloma, leukemia has the largest pipeline, with 798 products in active development.

Read more 
Takeda initiates world’s first norovirus vaccine field trial

Takeda initiates world’s first norovirus vaccine field trial

21 Jun 2016

Read more 
Scancell suspends trial of melanoma drug

Scancell suspends trial of melanoma drug

20 Jun 2016

Ongoing quality control analysis has revealed that the stored drug product is no longer within the original specification.

Read more 
PaizaBio: China approves Drug Marketing Authorization Holder pilot plan

PaizaBio: China approves Drug Marketing Authorization Holder pilot plan

20 Jun 2016

Move approves the use of contract manufacturing organisations.

Read more 
Multi-centre trial to test new treatment for chronic cough

Multi-centre trial to test new treatment for chronic cough

20 Jun 2016

Trial to test the first new cough drug in 50 years.

Read more 
NovaBiotics' cysteamine (Nylexa) breaks resistance in MDR bacteria

NovaBiotics' cysteamine (Nylexa) breaks resistance in MDR bacteria

19 Jun 2016

Results show that cysteamine reverses resistance to clinically important antibiotic classes such as aminoglycosides, fluoroquinolones, macrolides, folate pathway inhibitors and beta-lactams.

Read more 
ARIAD completes strategic review and announces plans for growth

ARIAD completes strategic review and announces plans for growth

19 Jun 2016

Key outcome of the strategic review is a commitment to commercializing brigatinib in the US, subject to approval by the FDA.

Read more 
Breakthrough combination for patients with skin cancer receives fast-tracked ‘yes’ from NICE

Breakthrough combination for patients with skin cancer receives fast-tracked ‘yes’ from NICE

17 Jun 2016

This represents one of the fastest ever approvals by NICE – UK patients will be the first to benefit across Europe.

Read more 
NICE denies NHS patients access to Vertex's Orkambi

NICE denies NHS patients access to Vertex's Orkambi

17 Jun 2016

“As a result of applying the wrong appraisal process, approximately 2,700 people in England who could benefit from Orkambi are being forced to continue waiting for access.”

Read more 
Zika vaccine race overlooks need for global strategy to combat mosquito-borne diseases

Zika vaccine race overlooks need for global strategy to combat mosquito-borne diseases

16 Jun 2016

Vast majority of Zika vaccine products are currently in early preclinical trials, indicating that it will take many years until one of them receives market approval, says GlobalData.

Read more 
Novartis expands partnership with Medicines for Malaria Venture to develop next-generation antimalarial treatment

Novartis expands partnership with Medicines for Malaria Venture to develop next-generation antimalarial treatment

15 Jun 2016

KAF156 belongs to a novel class of antimalarials that act against both the blood and liver stages of the parasite's lifecycle.

Read more